The tariff classification of safety needles and pen cartridge holders from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for safety needles will be 9018.32.0000, HTSUS, which provides for “Tubular metal needles and needles for sutures and parts and accessories thereof.” The rate of duty will be free.
- The applicable subheading for pen cartridge holders will be 9018.39.0050, HTSUS, which provides for “instruments and appliances used in medical, surgical, dental or veterinary sciences; "other" syringes, needles, catheters, cannulae and the like and parts and accessories thereof.” The rate of duty will be free.
Ruling text
In your letter dated July 7, 2026, you requested a tariff classification ruling. The items under consideration are safety needles and pen cartridge holders. Both items are imported separately, not in assembled form, and without any medication or active substance included. They are distinct items used exclusively in the assembly of the BesremiPen - a prefilled, self-injector device. The safety needles are sterile, single-use needles designed with a snap-fit mechanism rather than a threaded design.
This prevents removal and reuse after use, consistent with their intended safety purpose. As previously submitted information, the safety needles are packaged in boxes containing 12 cartons, with each carton holding 100 units. The primary function of the safety needles is to deliver formulation buffers to a skin injection pad. Each safety needle is valued at less than $1. The pen cartridge holders are components designed with a snap-fit mechanism.
Upon importation into the United States, they are intended to be assembled with the cartridge, stopper plunger, and dosing mechanism device port to form a subassembly of the BesremiPen. Their primary function is to connect a compatible safety needle to the rest of the device. Based on previously submitted information and the image provided, the pen cartridge holders are packaged in boxes containing 100 units, with each unit valued at less than $1.
After importation, the safety needles and pen cartridge holders undergo a structured, multi-stage domestic preparation process to create demonstration articles used exclusively for soliciting orders for BesremiPen.
You state that these demonstration articles are clearly distinguished from the ordinary commercial BesremiPen, as they are prefilled with saline or buffer solution rather than the actual medication, distributed free of charge to healthcare professionals along with an injection pad, and safely disposed of following the demonstration.
You also claim that the company maintains traceable internal records demonstrating that the imported items are used solely for demonstration and solicitation of orders and can track the items from importation through use and disposal.
You suggest the tariff classification for the safety needles and pen cartridge holders under the subheading 9811.00.60, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Any sample (except samples covered by heading 9811.00.20 or 9811.00.40), valued not over $1 each, or marked, torn, perforated or otherwise treated so that it is unsuitable for sale or for use otherwise than as a sample, to be used in the United States only for soliciting orders for products of foreign countries.” We disagree.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N362922).